Novavax (NVAX) Misses Q1 EPS by 13c; Offers FY22 Revenue Guidance
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $7.96 +0.13%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
FRMM, PETS, DARE, More
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
FRMM, PETS, DARE, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q1 EPS of $2.56, $0.13 worse than the analyst estimate of $2.69. Revenue for the quarter came in at $704 million versus the consensus estimate of $845.2 million.
GUIDANCE:
Novavax sees FY2022 revenue of $4-5 billion.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Gaxos.ai Inc. (GXAI) Reports Q2 EPS of $0.02
- Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
